Start Your Search
Poster Display session (Friday) (ID 65)
- Event: ELCC 2018
- Type: Poster Display session
- Presentations: 1
- Coordinates: 4/13/2018, 12:30 - 13:00, Hall 1
230P - Experience with the implant of vascular access devices by medical oncologists in a non-surgical setting (ID 465)
12:30 - 13:00 | Presenting Author(s): A. Revuelta
Totally implantable central venous catheters are widely used in the management of patients (pts) with malignant diseases to facilitate drug delivery for the new therapeutic protocols. These are based on continuous administration and higher doses of chemotherapeutic agents with relative phlebitis problems and supportive treatment. Staff of our department, specially trained in the routine implantation of central venous accesses were in charge of the procedure. The technique was carried out under local anesthesia in a special suite of day hospital, under strict aseptic measures without fluoroscopic control.
From Sep 94 to January 2017, 1665 devices (port-a-cath systems [PS]) were implanted in 1627 pts, with a median age of 50.5 yr (range 14–81), and median K.I. 70% (50–100), female 982/male 683. Venous access: right interior jugular 983, left subclavian 316, right subclavian 333, left interior jugular 33. A thorax X-ray was performed after each procedure and in 216 pts prophylactic antibiotics were given.
The venous access remained implanted a median of 438 days (1- +2210). Complications occurred in 266 placements (16%): infections 116 (7%); deep venous thrombosis 66 (4%) obstruction 10 (0.6%); malpositioned 16 (2%); fractures/migration 28 (1.7%); pneumothorax 6 (0.32%); local skin necrosis 7 (0.6%). 520 devices were removed, 347 (66%) after completing planned therapy, and 173 (34%) due to complications [Infections (92), migration (22), malposition (12), venous thrombosis (26), obstruction (11) and skin necrosis (10)]. Cost-effectiveness of venous catheters in a non-surgical setting compared with devices implanted by interventional vascular radiologists in operating room turned out to be 1000 euro cheaper for each device.
Our experience suggests that implant of vascular access devices by medical oncologist in a non-surgical setting has similar or even less complications and is more cost effective with regard to radiology suite and operating room placement procedures.
Clinical trial identification:
Legal entity responsible for the study:
Has not received any funding
All authors have declared no conflicts of interest.
Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.